A method of producing a final product from a wastewater dissolved air flotation (DAF) sludge which includes the following dewatering step: 5dewatering of the sludge, an aged sludge or a pre-processed sludge to produce a sludge filter cake and a filtrate; such that the pre-processed is sludge, or aged sludge, that has undergone additional processing steps prior to dewatering and aged sludge is sludge that has been stored for a period of time, wherein the dewatering step is a mechanical dewatering step 10 carried out at a maximum of 30 C. which results in a sludge filter cake that does not flow under its own mass.

A method of producing a final product from a wastewater dissolved air flotation (DAF) sludge which includes the following dewatering step: 5dewatering of the sludge, an aged sludge or a pre-processed sludge to produce a sludge filter cake and a filtrate; such that the pre-processed is sludge, or aged sludge, that has undergone additional processing steps prior to dewatering and aged sludge is sludge that has been stored for a period of time, wherein the dewatering step is a mechanical dewatering step 10 carried out at a maximum of 30 C. which results in a sludge filter cake that does not flow under its own mass.

The invention herein is directed to pig waste silage, which is derived from the conversion of pig waste, a fermentable sugar source, and a lactic acid fermentable culture, thereby pig waste is transformed into a nitrogen-rich, crude protein concentrate ingredient, suitable for consumption by cattle, sheep, and goat diets. The pig waste silage of the invention herein is a crude protein source that can lower operational costs for cattle and other ruminant producers, by using less protein-based grains, as well as reduction in greenhouse gas emissions, through a better and more efficient digestion of ruminants, based on physiological principles.

The present invention relates to compositions and methods for a pet food palatant composition including mixed alkali metal pyrophosphates.

The invention relates to a method for producing a meat-based animal feed concentrate. The invention also relates to a meat-based animal feed concentrate which can be obtained according to the claimed method, to a meat-based animal drink, to the use of the meat-based animal drink for carnivorous household pets and to a packaging unit for the meat-based animal feed concentrate and/or the meat-based animal drink.

The invention relates to a method for producing a meat-based animal feed concentrate. The invention also relates to a meat-based animal feed concentrate which can be obtained according to the claimed method, to a meat-based animal drink, to the use of the meat-based animal drink for carnivorous household pets and to a packaging unit for the meat-based animal feed concentrate and/or the meat-based animal drink.

Pet food products are provided herein that comprise a reconstituted animal material, itself comprising an animal protein and micro-particulate denatured whey protein isolate having a volume distributed mean particle diameter (D[4,3]) between 37.81 m and no more than 70 m.

Pet food products are provided herein that comprise a reconstituted animal material, itself comprising an animal protein and micro-particulate denatured whey protein isolate having a volume distributed mean particle diameter (D[4,3]) between 37.81 m and no more than 70 m.

Described herein are compositions and methods that involve use of omega-3 polyunsaturated fatty acids (e.g., fish oil and/or flax oil) as supplements to colostrum. When administered to newborn calves the combination of colostrum with fish oil and/or flax oil can improve the health and immune function of the calf.

The present invention is a new method and composition that enhance bone repair, formation, maintenance and slowing of bone resorption. The present invention relates to methods and compositions that enhance collagen formation, tendon health and tendon injury healing, bone maintenance and bone injury healing, and the prevention and treatment of metabolic diseases. The present invention is a part of the therapy to maintain bone health among patients with diabetic bone resorption and others with metabolic disorders. In one embodiment, the composition is a composite of hydroxyapatite and an organic matrix composed of milk pH-dependent serum proteins, i.e., bone morphogenic proteins (BMP), milk serum-derived specific proteins (MSSP), and milk serum derived proteins.